Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Centrica ( (GB:CNA) ) is now available.
Centrica has disclosed that executive directors Christopher O’Shea and Russell O’Brien have each acquired ordinary shares under the company’s Share Incentive Plan, in line with regulatory requirements for reporting transactions by persons discharging managerial responsibilities. The acquisitions, comprising both partnership and matching shares administered by Equiniti Share Plan Trustees, are relatively small in value but underscore ongoing alignment between senior management and shareholders, and reflect the routine operation of Centrica’s employee share ownership arrangements.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £2.18 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Neutral.
Centrica’s overall stock score is driven by strong corporate events, particularly the share buyback program and strategic acquisitions, which enhance shareholder value. However, the score is tempered by a challenging valuation due to a negative P/E ratio and mixed technical indicators.
To see Spark’s full report on GB:CNA stock, click here.
More about Centrica
Centrica plc is a UK-based energy company listed on the London Stock Exchange under the ticker CNA. The group operates through a range of energy and services businesses and its ordinary shares are registered in England and Wales with ISIN GB00B033F229, reflecting its position as a prominent player in the UK energy market.
Average Trading Volume: 20,100,145
Technical Sentiment Signal: Buy
Current Market Cap: £8.18B
For detailed information about CNA stock, go to TipRanks’ Stock Analysis page.

